Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GuARDS Trial of dexamethasone in adults with acute respiratory distress syndrome
ISRCTN15076735Phase 4Recruiting
- Sponsor
- University of Edinburgh
- Start
- Mar 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 4, randomised, open-label trial of dexamethasone in acute respiratory distress syndrome (ARDS) (2 arms), sponsored by University of Edinburgh. Primary endpoint: All-cause mortality at 60 days. Started Mar 2024; status: recruiting.
02
Drugs
dexamethasone
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on ISRCTN15076735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN15076735.